돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 652생성일: 2026년 10월 24일

1-Bromo-4-iodobenzene → 1-(4-Bromophenyl)-4-piperidin-1-ylpiperidine

https://huagongshe.com/ko/reaction/652

반응식

참여 물질

역할이름HCID투입량
반응물1-Bromo-4-iodobenzeneHCID 11522—
반응물1,4'-BipiperidineHCID 78607—
시약Sodium t-butoxideHCID 23676156—
촉매1,1'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(1,1-diphenylphosphine)HCID 636044—
촉매Bis(dibenzylideneacetone)palladiumHCID 9811564—
용매TolueneHCID 1140—
생성물1-(4-Bromophenyl)-4-piperidin-1-ylpiperidineHCID 2313082164.41%

반응 조건

온도80 °C

반응 단계

TRIS(DIBENZYLIDENEACETONE)DIPALLADIUM(0) (0.162 g, 0.18 mmol) was added to 1,4'-bipiperidine (0.595 g, 3.53 mmol), 1-bromo-4-iodobenzene (1.000 g, 3.53 mmol), (9,9-dimethyl-9H-xanthene-4,5-diyl)bis(diphenylphosphine) (0.205 g, 0.35 mmol) and sodium 2-methylpropan-2-olate (0.408 g, 4.24 mmol) in toluene (10 mL). The resulting mixture was degassed again and was stirred at 80 °C for 18 hours under nitrogen. The reaction mixture was cooled to room temperature and filtered then the filtrate was diluted with EtOAc (50 mL), and washed sequentially with water (50 mL), water (50 mL), and saturated brine (50 mL). The organic layer was dried over MgSO4, filtered and evaporated to afford crude product. The crude product was purified by flash silica chromatography, elution gradient 0 to 10% MeOH in DCM. Pure fractions were evaporated to dryness to afford 1'-(4-bromophenyl)-1,4'-bipiperidine (0.736 g, 64.4 %) as a pale brown oil.

출처 및 근거

출처 데이터셋750 AstraZeneca ELN dataset
ORD IDord-1342ffbeb4634245a6963094cc9535b6
출처 메모750 AstraZeneca ELN dataset